ENTITY

KYAN Therapeutics (2198779D US)

Analysis

Health Care • Singapore

KYAN Therapeutics, Inc. is a biotechnology company. The Company tackles the complexity of cancer by combining small data AI and biological experiments. KYAN Therapeutics serves customers in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00